AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and…

By Sidney C. Smith, Emelia J. Benjamin, R. Bonow, L. Braun, M. Creager, B. Franklin, R. Gibbons, S. Grundy, L. Hiratzka, Daniel W. Jones and 8 more. Circulation, 2011

2,055 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/d0122e404230e9e36a5a2c690ed5bb6094b9ff52

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. G. Fonarow
2. T. Horwich
3. J. Halperin
4. J. Januzzi
5. Judith Hochman
6. M. Creager
7. C. Yancy
8. M. Drazner

In Surgery

1. Judith Hochman
2. M. Creager

Citations in the corpus

• Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane Systematic Review and Meta-Analysis. (2016, background): “While exercise training remains a cornerstone intervention, international guidelines consistently recommend the provision of comprehensive rehabilitation that includes education and psychological input focusing on health and lifestyle behaviour change, risk factor modification, and psychosocial well”
• 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013, background): “The beneficial effects of aspirin and clopidogrel with fibrinolytic therapy are well established.(254,257,263,264) These agents should be given before or with the fibrinolytic.”
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013, background): “, of the coronary, cerebral, or peripheral blood vessels) are likely to develop HF, and clinicians should seek to control vascular risk factors in such patients according to guidelines (13).”
• 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. (2014, neutral): “Coronary Artery Bypass Graft Surgery ACCF/AHA 2011 (11) Hypertrophic Cardiomyopathy ACCF/AHA 2011 (12) Percutaneous Coronary Intervention ACCF/AHA/SCAI 2011 (13) Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease AHA/ACCF 2011 (14)”